Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/VAXCYTE-INC-108367227/news/Vaxcyte-Completes-Enrollment-of-Phase-1-2-Study-Evaluating-VAX-31-for-the-Prevention-of-Invasive-Pne-45831124/?utm_source=whatsapp&utm_medium=social&utm_campaign=share